SCHEMBL26625828

SCHEMBL26625828

OCc1cc(Br)cc2c1CCC2

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.34
▸ LMNA P02545 2/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ CCNB2 O95067 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ CCNB3 Q8WWL7 1/20 0.32
▸ PRNP P04156 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ GNG2 P59768 1/20 0.31
▸ GNB1 P62873 1/20 0.31
▸ NLRP3 Q96P20 1/20 0.30
▸ PTGDR2 Q9Y5Y4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31603076 0.82 PRNP (0.33) PRNPRXFP1GNG2GNB1
SCHEMBL25260735 0.75 ALDH1A1 (0.30) ALDH1A1
SCHEMBL30068862 0.75 ALDH1A1 (0.30) ALDH1A1
SCHEMBL22618624 0.74 BCL2L1 (0.42) ALDH1A1MAPTL3MBTL1CCNB2CDK1
SCHEMBL29386148 0.74 BCL2L1 (0.42) ALDH1A1MAPTL3MBTL1CCNB2CDK1
SCHEMBL21439024 0.73 LMNA (0.33) ALDH1A1LMNACYP1A2MAPTCYP2C9
SCHEMBL31359561 0.73 LMNA (0.33) ALDH1A1LMNACYP1A2MAPTCYP2C9
SCHEMBL22859112 0.73 CYP2C19 (0.48) ALDH1A1MAPT
SCHEMBL31150899 0.72 ALDH1A1 (0.32) ALDH1A1MAPTRXFP1
SCHEMBL29150720 0.72 ALDH1A1 (0.32) ALDH1A1MAPTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326770-A1 BENZOTRIAZOLE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-10-23 — — US disclosed
US-20250282724-A1 BENZOTRIAZOLE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-09-11 — — US disclosed
US-12378260-B2 Benzotriazole compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-08-05 — — US disclosed
WO-2025108255-A1 POLYCYCLIC DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海齐鲁制药研究中心有限公司 2025-05-30 — — WO disclosed
US-20250092064-A1 BENZOTRIAZOLE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-03-20 — — US disclosed
EP-4509504-A1 BENZOTRIAZOLE COMPOUND Daiichi Sankyo Company, Limited (JP) 2025-02-19 — — EP disclosed
CN-119173511-A Benzotriazole compounds 第一三共株式会社 2024-12-20 — — CN disclosed
WO-2023210741-A1 BENZOTRIAZOLE COMPOUND 第一三共株式会社 2023-11-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250092064-A1 BENZOTRIAZOLE COMPOUND NFE2L2, BPTF, KEAP1 ALDH1A1 416/4885LMNA 2933/4885CYP1A2 1379/4885
US-12378260-B2 Benzotriazole compound NFE2L2, BPTF, KEAP1 ALDH1A1 416/4885LMNA 2933/4885CYP1A2 1379/4885
US-20250326770-A1 BENZOTRIAZOLE COMPOUND KEAP1, NFE2L2, TXNRD2 ALDH1A1 588/4885LMNA 2817/4885CYP1A2 1798/4885
US-20250282724-A1 BENZOTRIAZOLE COMPOUND NFE2L2, BPTF, KEAP1 ALDH1A1 416/4885LMNA 2933/4885CYP1A2 1379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback